MALAT1 and glioblastoma: Similar studies using Malat1-targeting siRNAs have been conducted in other cancer types, such as glioblastoma, ovarian, colorectal (CRC), gallbladder, gastric, osteosarcoma, and esophageal, etc. [88,106,107,140,142,150,151,152].